Oligoastrocytoma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(24 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Oligoastrocytoma was first discovered by Bailey and Cushing, in 1926.<ref name=history>Definition of oligodendroglial tumors. Seattlecca.org 2015. https://www.seattlecca.org/client/Chamberlain_Oligodendroglioma.pdf. Accessed on October 15, 2015</ref>
The broad topic "oligodendroglial tumors", of which oligoastrocytoma is a part of, was first described by Bailey and Cushing in 1926. They reported that gliomas were formed by transformation of glial cells. Celli et al in 1994 gave the name of "oligoastrocytoma" to those oligodendroglial tumors where the [[astrocytes]] formed more than 20% of the tumor cells.


==Historical Perspective==
==Historical Perspective==
*The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the [[tumor]] cells are morphologically similar to [[oligodendrocyte]]s.<ref name="pmid19322536">{{cite journal| author=Hartmann C, von Deimling A| title=Molecular pathology of oligodendroglial tumors. | journal=Recent Results Cancer Res | year= 2009 | volume= 171 | issue= | pages= 25-49 | pmid=19322536 | doi=10.1007/978-3-540-31206-2_2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19322536 }} </ref>
*The broad topic "oligodendroglial tumors" was first described by Bailey and Cushing in 1926.<ref name="bailey">{{cite journal|title=A classification of the tumours of the glioma group on a histogenetic basis, with a correlated study of prognosis. By Percival Bailey and Harvey Cushing. Medium 8vo. Pp. 175, with 108 illustrations. 1926. Philadelphia, London, and Montreal: J. B. Lippincott Company. 21s. net|journal=British Journal of Surgery|volume=14|issue=55|year=1927|pages=554–555|issn=00071323|doi=10.1002/bjs.1800145540}}</ref><ref name="pmid16623651">{{cite journal| author=Chowdhary S, Chamberlain MC| title=Oligodendroglial tumors. | journal=Expert Rev Neurother | year= 2006 | volume= 6 | issue= 4 | pages= 519-32 | pmid=16623651 | doi=10.1586/14737175.6.4.519 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16623651 }} </ref>
*Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926.<ref name="pmidhttp://dx.doi.org/10.1093/brain/49.4.578">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=http://dx.doi.org/10.1093/brain/49.4.578 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref>
*The [[anaplastic]] nature of oligodendroglial tumors was described by Kernohan based on the features such as [[endothelial|endotheliael proliferation]], [[atypia|nuclear atypia]], [[mitoses]], and [[necrosis]].
*Their name is derived from the Greek words "''oligo''" meaning few and "''dendro''" meaning trees.
*The studies by Zulch, Kleihues et al, and Daumas-Duport system (St. Anne-Mayo schema) resulted in the formulation of the WHO classification of CNS tumors, where oligoastrocytoma and [[anaplastic|anaplastic oligoastrocytoma]] were graded as WHO grade II (low-grade) and WHO grade III (high-grade) tumor, respectively.<ref name="pmid17618441">{{cite journal| author=Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al.| title=The 2007 WHO classification of tumours of the central nervous system. | journal=Acta Neuropathol | year= 2007 | volume= 114 | issue= 2 | pages= 97-109 | pmid=17618441 | doi=10.1007/s00401-007-0243-4 | pmc=PMC1929165 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17618441  }} </ref><ref name="pmid2437411">{{cite journal| author=Daumas-Duport C, Scheithauer BW, Kelly PJ| title=A histologic and cytologic method for the spatial definition of gliomas. | journal=Mayo Clin Proc | year= 1987 | volume= 62 | issue= 6 | pages= 435-49 | pmid=2437411 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2437411 }} </ref>
*In 2009, Kevin Smith was the first to discover the association between ''[[mutation|NJDS]]'' mutation and development of oligodendroglioma.<ref name=history>Etiology of oligodendroglioma. Wikipedia. https://en.wikipedia.org/wiki/Oligodendroglioma</ref>
*Celli et al in 1994 gave the name of "oligoastrocytoma" to those oligodendroglial tumors where the [[astrocytes]] formed more than 20% of the tumor cells.<ref name="pmid7885546">{{cite journal| author=Celli P, Nofrone I, Palma L, Cantore G, Fortuna A| title=Cerebral oligodendroglioma: prognostic factors and life history. | journal=Neurosurgery | year= 1994 | volume= 35 | issue= 6 | pages= 1018-34; discussion 1034-5 | pmid=7885546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7885546  }} </ref>
*[[radiation|Irradiation]] of [[pituitary adenoma]] was also discovered to be associated with oligodendroglioma by Kevin Smith et al.


==References==
==References==
Line 23: Line 22:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 02:39, 23 October 2019

Oligoastrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligoastrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligoastrocytoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligoastrocytoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligoastrocytoma historical perspective

CDC on Oligoastrocytoma historical perspective

Oligoastrocytoma historical perspective in the news

Blogs on Oligoastrocytoma historical perspective

Directions to Hospitals Treating Glioma

Risk calculators and risk factors for Oligoastrocytoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

The broad topic "oligodendroglial tumors", of which oligoastrocytoma is a part of, was first described by Bailey and Cushing in 1926. They reported that gliomas were formed by transformation of glial cells. Celli et al in 1994 gave the name of "oligoastrocytoma" to those oligodendroglial tumors where the astrocytes formed more than 20% of the tumor cells.

Historical Perspective

  • The broad topic "oligodendroglial tumors" was first described by Bailey and Cushing in 1926.[1][2]
  • The anaplastic nature of oligodendroglial tumors was described by Kernohan based on the features such as endotheliael proliferation, nuclear atypia, mitoses, and necrosis.
  • The studies by Zulch, Kleihues et al, and Daumas-Duport system (St. Anne-Mayo schema) resulted in the formulation of the WHO classification of CNS tumors, where oligoastrocytoma and anaplastic oligoastrocytoma were graded as WHO grade II (low-grade) and WHO grade III (high-grade) tumor, respectively.[3][4]
  • Celli et al in 1994 gave the name of "oligoastrocytoma" to those oligodendroglial tumors where the astrocytes formed more than 20% of the tumor cells.[5]

References

  1. "A classification of the tumours of the glioma group on a histogenetic basis, with a correlated study of prognosis. By Percival Bailey and Harvey Cushing. Medium 8vo. Pp. 175, with 108 illustrations. 1926. Philadelphia, London, and Montreal: J. B. Lippincott Company. 21s. net". British Journal of Surgery. 14 (55): 554–555. 1927. doi:10.1002/bjs.1800145540. ISSN 0007-1323.
  2. Chowdhary S, Chamberlain MC (2006). "Oligodendroglial tumors". Expert Rev Neurother. 6 (4): 519–32. doi:10.1586/14737175.6.4.519. PMID 16623651.
  3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A; et al. (2007). "The 2007 WHO classification of tumours of the central nervous system". Acta Neuropathol. 114 (2): 97–109. doi:10.1007/s00401-007-0243-4. PMC 1929165. PMID 17618441.
  4. Daumas-Duport C, Scheithauer BW, Kelly PJ (1987). "A histologic and cytologic method for the spatial definition of gliomas". Mayo Clin Proc. 62 (6): 435–49. PMID 2437411.
  5. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A (1994). "Cerebral oligodendroglioma: prognostic factors and life history". Neurosurgery. 35 (6): 1018–34, discussion 1034-5. PMID 7885546.


Template:WikiDoc Sources